Protective role of Interleukin-18 against Fas-mediated liver injury

International Journal of Molecular Medicine

Volumn 22, Issue 1, 2008, Pages 43-48

  Yamamoto, Norihiko ^a   Murata, Kazumoto ^b   Yoneda, Kentaro ^a   Fuke, Hiroyuki ^a   Yamaguchi, Yumi ^a   Ito, Keiichi ^a   Sugimoto, Kazushi ^a   Shiraki, Katsuya ^a   Yamanaka, Kei Ichi ^a   Mizutani, Hitoshi ^a   Takei, Yoshiyuki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Fas mediated apoptosis; Interleukin 18; Nuclear factor B; X linked inhibitors of apoptosis

Indexed keywords

CASPASE 3; FAS ANTIBODY; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; RECOMBINANT INTERLEUKIN 18; X LINKED INHIBITOR OF APOPTOSIS; FAS LIGAND; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIVER INJURY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; LIVER CELL; LIVER DISEASE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL LINE, TUMOR; FAS LIGAND PROTEIN; HEPATOCYTES; INTERLEUKIN-18; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT PROTEINS;

EID: 52049124800     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.22.1.43     Document Type: Article

References (23)

1. Sugihara I: Interleukin-18 (IL-18) and infectious disease, with special emphasis on disease induced by intracellular pathogen. Microbes Infect 2: 1257-1263, 2000.
2. Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S-I, Yamauchi H, Hiroshi K, Takeda K, Tagawa Y-I, Iwakura Y, Kayagaki N, Kurimoto M, Okamura H, Hada T, Yagita H, Akira S, Nakanishi K and Higashino K: IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol 162: 1662-1668,1999.
3. Kimura K, Kakimi K, Wieland S, Guidotti LG and Chisari FV: Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 76: 10702-10707, 2002.
4. Fujioka N, Akazawa R, Ohashi K, Ikeda M and Kurimoto M: Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73: 2401-2409, 1998.
5. Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Ohashi K, Ikeda M and Kurimoto M: In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 11: 593-599, 1999.
6. Konishi H, Tsutsui H, Murakami T, et al: IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 99: 11340-11345, 2002.
7. Tsutsui H, Adachi K, Seki E and Nakanishi K: Cytokine-induced inflammatory liver disease. Curr Molec Med 3: 545-559, 2003.
8. Tsutsui H, Kawagaki N, Kuida K, Nakano H, Hayashi N, Takeda K, Matsui K, Kashiwamura S, Hada T, Akira S, Yagita H, Okamura H and Nakanishi K: Caspase-1 independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11: 359-367, 1999.
9. De la Barrera S, Finiasz M, Fink S, Ilarregui J, Aleman M, Olivares L, Franco MC, Pizzariello G and Del Carmen Sasiain M: NK cells modulate the cytotoxic activity generated by mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13. Clin Exp Immunol 135: 105-113, 2004.
10. Galle PR and Krammer PH: CD95-induced apoptosis in human liver disease. Semin Liver Dis 18: 141-151, 1998.
11. Nanji AA: Apoptosis and alcoholic liver disease. Semin Liver Dis 18: 187-190, 1998.
12. Chandrasekar B, Vemula K, Surabhi RM, et al: Activation of intrinsic and extrinsic proapoptotic signaling pathway in interleukin-18-mediated human cardiac endothelial cell death. J Biol Chem 279: 20221-20233, 2004.
13. Takehara T, Hayashi N, Tatsumi T, Kanto T, Mita E, Sasaki Y, Kasahara A and Hori M: Interleukin 1ß protects mice from Fas-mediated hepatocyte apoptosis and death. Gastroenterology 117: 661-668, 1999.
14. Asakawa M, Kono H, Amemiya H, Matsuda M, Suzuki T, Maki A and Fujii H: Role of interleukin-18 and its receptor in hepatocelllular carcinoma associated with hepatitis C virus infection. Int J Cancer 118: 564-570, 2005.
15. Schreiber E, Matthias P, Muller MM and Schaffer W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989.
16. Stehlik C, Martin R, Kumabashiri I, Schmid JA, Binder BR and Lipp J: Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. JEM 188: 211-216, 1998.
17. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin AS Jr: NF-kappa B antiapoptosis: induction of TRAF-1 and TRAF-2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998.
18. Finotto S, Siebler J, Hausding M, Schipp M, Wirtz S, Klein S, Protschka M, Doganci A, Lehr HA, Trautwein C, Khosravi-Fahr R, Strand D, Lohse A, Galle PR, Blessing M and Neurath MF: Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53: 392-400, 2004.
19. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okumura H, Miyazawa Y and Kaneda K: IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 157: 3967-3973, 1996.
20. Dao T, Ohashi K, Kayano T, Kurimoto M and Okumura H: Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 173: 230-235, 1996.
21. Lee MO, Choi YH, Shin E-C, Kang HJ, Kim YM, Jeong SY, Seong JK, Yu DY, Cho H, Park JH and Kim SJ: Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. J Hepatol 37: 380-386, 2002.
22. Iimuro Y, Nishimura T, Hellerbrand C, Behrus KE, Schoonhoven R, Grisham JW and Brenner DA: NF kappa B prevents apoptosis and liver dysfunction during liver degeneration. J Clin Invest 101: 802-811, 1998.
23. Begg AA, Sha WC, Bronson RT, Ghosh S and Baltimore D: Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF kappa B. Nature 376: 167-170, 1995.